New - European Medical Journal

Continue

News

EMJ
Cardiology
21 Apr 2016

Heart Attack Patients More Depressed but Get Less Antidepressants

Athens, Greece – 16 April 2016: Heart attack patients are more depressed but are less often prescribed antidepressants than people who have not had a…
EMJ
Respiratory
19 Apr 2016

Structure of Coronavirus Defence Offers Clues to Treatment

DECIPHERING the structure of a key protein in the coronavirus HKU1, a member of a family of deadly viruses, has provided a promising avenue for…
EMJ
Respiratory
19 Apr 2016

First 3D Printed ‘Sneezometer’ Opens Doors to Diagnosis

PIONEERING use of 3D printing technology has enabled the development of simple, non-intrusive, and cost-effective spirometry for the diagnosis of…
EMJ
Rheumatology
15 Apr 2016

EULAR Crowdsources Inspirational Stories to Educate the World about Rheumatic and Musculoskeletal Diseases

Sofia, Bulgaria (15 April 2016): EULAR and the Standing Committee of PARE (People with Arthritis/Rheumatism) has launched ‘The Future In Your Hands’…
EMJ
Hepatology
15 Apr 2016

UK Study Shows Rifaximin-α Significantly Reduces Hospital Resource Use for Patients with Hepatic Encephalopathy

LONDON, UK, Thursday 14 April, 07:00 BST: Norgine B.V. presented new positive UK real world practice data from the IMPRESS retrospective observational…
EMJ
Oncology
15 Apr 2016

Celyad Will Present Its NKR-2 Immuno-Oncology Clinical Program at 2016 ASCO Annual Meeting

Mont-Saint-Guibert, Belgium: Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…
EMJ
Oncology
15 Apr 2016

Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy

GENEVA, Switzerland, 15 April 2016: Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit…
EMJ
Oncology
15 Apr 2016

Immunotherapy with Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma

GENEVA, Switzerland, 14 April 2016: Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and…